An analysis of research biopsy core variability from over 5000 prospectively collected core samples
Deepak Bhamidipati, Anuj Verma, Dawen Sui, Dipen M. Maru, Grace Mathew, Wenhua Lang, Juan Posadas, J Hein, Scott Kopetz, P. Andrew Futreal, Ignacio I. Wistuba, Sanjay Gupta, J. Jack Lee, Michael J. Overman, Alda L. Tam
Abstract
Factors correlated with biopsy tissue adequacy and the prevalence of within-biopsy variability were evaluated. Totally, 1149 research biopsies were performed on 686 patients from which 5090 cores were assessed. Biopsy cores were reviewed for malignant percentage (estimated percentage of cells in the core that were malignant) and malignant area (estimated area occupied by malignant cells). Linear mixed models and generalized linear mixed models were used for the analysis. A total of 641 (55.8%) biopsies contained a core with <10% malignant percentage (inadequate core). The chance of an inadequate core was not influenced by core order, though the malignant area decreased with each consecutive core (p < 0.001). Younger age, bone biopsy location, appendiceal tumor pathology, and responding/stable disease prior to biopsy increased the odds of a biopsy containing zero adequate cores. Within-biopsy variability in core adequacy is prevalent and suggests the need for histological tumor quality assessment of each core in order to optimize translational analyses.